Education
About Us
Working with TipRanks
Follow Us
Fusen Pharmaceutical Co., Ltd. (HK:1652)
:1652
Total Valuation
Fusen Pharmaceutical Co., Ltd. has a market cap or net worth of HK$617.59M. The enterprise value is HK$603.14M.
Market CapHK$617.59M
Enterprise ValueHK$603.14M
Share Statistics
Fusen Pharmaceutical Co., Ltd. has 739,301,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding739,301,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Fusen Pharmaceutical Co., Ltd.’s return on equity (ROE) is -0.51 and return on invested capital (ROIC) is -8.84%.
Return on Equity (ROE)-0.51
Return on Assets (ROA)-0.15
Return on Invested Capital (ROIC)-8.84%
Return on Capital Employed (ROCE)-0.14
Revenue Per Employee288.27K
Profits Per Employee-168.39K
Employee Count1,131
Asset Turnover0.26
Inventory Turnover1.19
Valuation Ratios
The current PE Ratio of Fusen Pharmaceutical Co., Ltd. is ―. Fusen Pharmaceutical Co., Ltd.’s PEG ratio is -0.00701.
PE Ratio―
PS Ratio1.71
PB Ratio1.50
Price to Fair Value1.50
Price to FCF9.68
Price to Operating Cash Flow4.35
PEG Ratio-0.00701
Income Statement
In the last 12 months, Fusen Pharmaceutical Co., Ltd. had revenue of 326.03M and earned -188.78M in profits. Earnings per share was -0.26.
Revenue326.03M
Gross Profit162.64M
Operating Income-67.51M
Pretax Income-190.45M
Net Income-188.78M
EBITDA-39.07M
Earnings Per Share (EPS)-0.26
Cash Flow
In the last 12 months, operating cash flow was 133.73M and capital expenditures -76.30M, giving a free cash flow of 57.43M billion.
Operating Cash Flow133.73M
Free Cash Flow57.43M
Free Cash Flow per Share0.08
Dividends & Yields
Fusen Pharmaceutical Co., Ltd. pays an annual dividend of HK$0.004, resulting in a dividend yield of ―
Dividend Per ShareHK$0.004
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.12
52-Week Price Change-15.15%
50-Day Moving Average0.51
200-Day Moving Average0.44
Relative Strength Index (RSI)56.59
Average Volume (3m)3.78M
Important Dates
Fusen Pharmaceutical Co., Ltd. upcoming earnings date is Apr 7, 2026, TBA (Confirmed).
Last Earnings DateAug 29, 2025
Next Earnings DateApr 7, 2026
Ex-Dividend DateJun 07, 2022
Financial Position
Fusen Pharmaceutical Co., Ltd. as a current ratio of 0.60, with Debt / Equity ratio of 105.23%
Current Ratio0.60
Quick Ratio0.42
Debt to Market Cap0.69
Net Debt to EBITDA-9.28
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Fusen Pharmaceutical Co., Ltd. has paid 1.65M in taxes.
Income Tax1.65M
Effective Tax Rate>-0.01
Enterprise Valuation
Fusen Pharmaceutical Co., Ltd. EV to EBITDA ratio is -23.51, with an EV/FCF ratio of 16.00.
EV to Sales2.82
EV to EBITDA-23.51
EV to Free Cash Flow16.00
EV to Operating Cash Flow6.87
Balance Sheet
Fusen Pharmaceutical Co., Ltd. has HK$21.06M in cash and marketable securities with HK$383.69M in debt, giving a net cash position of -HK$362.64M billion.
Cash & Marketable SecuritiesHK$21.06M
Total DebtHK$383.69M
Net Cash-HK$362.64M
Net Cash Per Share-HK$0.49
Tangible Book Value Per ShareHK$0.46
Margins
Gross margin is 41.39%, with operating margin of -20.71%, and net profit margin of -57.90%.
Gross Margin41.39%
Operating Margin-20.71%
Pretax Margin-58.41%
Net Profit Margin-57.90%
EBITDA Margin-11.98%
EBIT Margin-20.60%
Analyst Forecast
The average price target for Fusen Pharmaceutical Co., Ltd. is HK$1.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$1.00
Price Target Upside19.05% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-43.46%
EPS Growth Forecast-96.48%